Paclitaxel and caboplatin in relapsed or metastatic nasopharyngeal carcinoma: A multicenter phase II study

Journal of B.U.ON.

Volumn 9, Issue 2, 2004, Pages 161-165

  Ciuleanu, Tudor E ^a   Fountzilas, G ^b   Ciuleanu, E ^a   Plataniotis, M ^b   Todor, N ^a   Ghilezan, N ^a  

^a Cancer Institute Ion Chiricuta Cluj Napoca   (Romania)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Carboplatin; Nasopharryngeal carcinoma; Paclitaxel; Phase II study

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BILIRUBIN; CARBOPLATIN; CREATININE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ADULT; ALOPECIA; ANEMIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BONE MARROW CELL; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; DOSE RESPONSE; DRUG SAFETY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; INFECTION; KIDNEY FUNCTION; LEUKOCYTE COUNT; LEUKOPENIA; LIFE EXPECTANCY; LIVER FUNCTION; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; MULTICENTER STUDY; MYALGIA; NASOPHARYNX CARCINOMA; NAUSEA AND VOMITING; NEUTROPENIA; NOSE SURGERY; OUTPATIENT CARE; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 4344712677     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Al Saraf M, Le Blanc M, Giri PG. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 1998; 16: 1310-1317.
2. International Nasopharyngeal Cancer Study Group Vumca I Trial: Preliminary results of randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (>N2, MO) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 1996; 35: 569-577.
3. Forastiere AA, Shank D, Neuberg D et al. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial (PA 390). Cancer 1998; 82: 2270-2274.
4. Fountzilas G, Athanassiades A, Samantas E et al. Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: A phase II study. Semin Oncol 1997; 24 (Suppl 2): S2-65, S2-67.
5. Fountzilas G, Athanassiades A, Kalogera-Fountzila A et al. Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer. Semin Oncol 1997; 24 (Suppl 19): S19-S32.
6. Hitt R, Hornedo J, Colomer R et al. Phase I-II study of escalating doses of paclitaxel + cisplatin with G-CSF (filgrastim) as first line therapy for head and neck carcinomas: Preliminary results. Proc Am Soc Clin Oncol 1995; 14: 300, A 868 (abstr).
7. Ciuleanu E, Todor N, Ghilezan N, Ciuleanu TE. A salvage regimen for relapsed nasopharyngeal carcinoma: paclitaxel and carboplatin. J BUON 1998; 3 (Suppl 1): 88, A 208 (abstr).
8. Ciuleanu TE, Ciuleanu E, Todor N, Ghilezan N. Paclitaxel and carboplatin salvage chemotherapy in relapsed nasopharyngeal carcinoma. Ann Oncol 1998; 9 (Suppl 4): 76, P365 (abstr).
9. Fountzilas G, Skarlos D, Athanassiades A et al. Paclitaxel by three hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of head and neck. Ann Oncol 1997; 8: 451-455.
10. Yeo W, Leung TWT, Chan ATC et al. A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma. Eur J Cancer 1998; 34, 13: 2027-2031.
11. Tan EH, Khoo KS, Wee J et al. Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Ann Oncol 1999; 10: 235-237.
12. Ciuleanu E, Ciuleanu TE, Todor N et al. Efficacy of paclitaxel in second line combination chemotherapy for relapsed nasopharyngeal carcinoma patients. Radioter Oncol Medic, 2001; 2: 192-196 (in Romanian).